Editor's key points † Perioperative platelet dysfunction is common in paediatric open heart surgery. † Changes in platelet aggregation were followed in 50 children undergoing cardiopulmonary bypass. † Platelet aggregation was reduced before operation in acyanotic but not cyanotic subjects, and decreased during surgery with slow recovery in both. † Platelet aggregation did not correlate with blood loss, and so does not appear to be a good predictor.
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While some studies indicate a reduction in platelet count and function, 2 -6 others report platelet hyperactivity in CHD. 7 8 Platelet aggregability has not yet been systematically investigated in children with cyanotic and acyanotic CHD. Cardiac surgery with cardiopulmonary bypass (CPB) affects platelets, and the resulting platelet exhaustion is considered to be an important risk factor for early postoperative blood loss and transfusion requirements. 9 -15 Bleeding, in turn, increases morbidity and mortality. Since allogeneic blood products and specifically platelet concentrate transfusions have a well-recognized infection risk, 16 prediction and prevention of transfusions by perioperative monitoring of platelet-dependent parameters could prove useful for management of haemostasis. Accordingly, the aim of our study was to compare preoperative platelet aggregation in paediatric patients with cyanotic or acyanotic CHD, and to describe the intra-and postoperative course of platelet function. Light transmission aggregometry in platelet-rich plasma has several limitations in paediatric surgical patients, such as the need for large sample volumes, long turn-around times, and poor standardization. 17 Multiple electrode aggregometry (MEA) is a relatively new method which measures electrical impedance changes in whole blood induced by platelet adhesion and aggregation onto metal wires. 18 MEA has been proven sensitive for platelet-inhibiting agents 19 20 and the effects of extracorporeal circulation during CPB. 13 21 MEA predicted adverse outcome in adult patients with coronary stents. 22 Small sample volumes, point-of-care analysis within 6 min, and availability of standardized agonists are features that make use of MEA intriguing in children undergoing heart surgery. We used MEA to explore the perioperative evolution of platelet aggregation in this high-risk population.
Methods

Subjects
After obtaining institutional review board approval and written informed consent from the parents, 50 consecutive children ,7 yr of age undergoing repair of cardiac malformations with CPB at the General Hospital Linz were included in a prospective non-interventional observational study. Exclusion criteria were hereditary bleeding disorders.
Patients were divided according to the direction of the shunt into a cyanotic group with a haemodynamically significant right-to-left shunt resulting in an arterial oxygen saturation under 90% (tetralogy of Fallot, transposition of the great arteries, hypoplastic left heart syndrome, double outlet right ventricle, pulmonary atresia) and an acyanotic group with a left-to-right shunt (ventricular septal defect, atrial septal defect, truncus arteriosus communis, atrial ventricular septal defect, or after correction of right-to-left shunting as first repair of malformation).
After performance of this study, reference values have been established for healthy infants, children, and adolescents. 23 Accordingly, subjects were respectively divided into three age groups: ≤12 months, 1.1-4, and 4.1-7 yr.
Anaesthesia and surgery
The operative and anaesthetic management was similar in all patients according to the hospital's standard operating procedures. Midazolam, cisatracurium and thiopental, or S-ketamine (in patients with Fallot) was used for induction, and sevoflurane and sufentanil were for maintenance of anaesthesia. A bolus of 400 units kg 21 unfractionated heparin was administered before institution of CPB. Additional doses of heparin were given on CPB to maintain an activated clotting time above 480 s. After CPB, heparin was neutralized with protamine sulphate, 1 mg protamine per 100 units of total heparin dose. The standard nonpulsatile CPB circuit with a membrane oxygenator and a roller pump was primed with human albumin 20% and crystalloids and applied with moderate hypothermia of 34-358C. Weaning off CPB was performed after rewarming to 368C using dobutamine, nitroglycerin, and milrinone (in single ventricle lesions). Patients received an i.v. bolus injection of 10 mg kg 21 tranexamic acid before surgery followed by an i.v. continuous infusion of 10 ml kg 21 h 21 until the end of surgery. Infusion therapy was performed with lactated Ringer's solution and 6% hydroxyethyl starch 130/0.4 according to the haemodynamic requirements at the discretion of the anaesthetist. Red blood cell (RBC) transfusions were given when the haematocrit was ,25% while on CPB and ,30% after CPB (35% in biventricular lesions). In the case of diffuse bleeding after weaning from CPB, despite neutralization of heparin and completion of surgical haemostasis, platelets were transfused as a first-line therapy, especially in neonates with low platelet counts before CPB. The rationale for transfusing platelets is the proposed platelet consumption during extracorporeal circulation. 24 After surgery, platelet count below 100 g litre 21 was the trigger for platelet transfusion in the case of clinical bleeding. Fresh-frozen plasma (FFP) was transfused in the case of persisting bleeding and prothrombin time .40% above control. Frequency and volume of transfused RBC, FFP, and platelet concentrates and also blood loss during the hospital stay were recorded. After surgery, activated partial thromboplastin time was maintained at 50-60 s using unfractionated heparin. Acyanotic patients more than 14 yr old received enoxaparin for thrombosis prophylaxis once daily starting at the first postoperative day.
Sample collection
Measurement time points were after induction of anaesthesia but before surgery, 15 min after start of CPB, at the end of surgery, at arrival to the intensive care unit, on the first postoperative day, and on the fifth postoperative day. Blood was drawn from an indwelling arterial catheter after discarding the first 2.6 ml. Blood was collected into commercially available 1.4 ml Monovette TM collection tubes (Sarstedt, Numbrecht, Germany) containing 1.2 mg ml 21 EDTA for whole-blood count (Sysmex XE-2100, Roche Diagnostics, Mannheim, Germany) and 2.6 ml Monovette TM collection tubes containing 25 mg ml 21 hirudin for MEA analyses. All tests were run at the hospital central laboratory 0.5-2 h after blood sampling. The results of the platelet function analyses were not provided to the anaesthetists, surgeons, or intensivists in charge. Platelet aggregometry was performed using the impedance aggregometer Multiplate w (Dynabyte, Munich, Germany), an instrument with five channels for parallel determinations. Three hundred microlitres of saline and 300 ml of hirudinized blood were pipetted into disposable cartridges containing a magnetic stirrer and two independent dual-sensor units of silver-covered electrodes. After incubating blood samples for 3 min at 378C, the following agonists were added (test name and final concentration in parenthesis): adenosine diphosphate (ADP test, 6.4 mM), arachidonic acid (ASPI test, 0.5 mM), or thrombin receptor-activating peptide (TRAP test, 32 mM) using commercially available test reagents for MEA analysis. The change in electrical impedance as a result of platelet aggregation and adhesion to the metal sensors was recorded and plotted against time.
Statistical analysis
The study was considered exploratory; therefore, sample size was not calculated a priori. Data of all parameters were examined by the Kolmogorov-Smirnov test for suitability for parametric testing. Differences in laboratory data between cyanotic and acyanotic patients were assessed using Student's t-test, Wilcoxon's test, or x 2 test as appropriate. Analysis of variance for repeated measures with post hoc comparisons by two-sided paired t-test was used to assess changes during the observation period. A P-value of ,0.05 was considered statistically significant. Linear regression was used to analyse the relationship between platelet parameters, bleeding, and transfusion requirements. Data are presented as mean (standard deviation) or median (minimum, maximum).
Results
Subject characteristics are presented in Table 1 . In the cyanotic group, all 25 subjects were younger than 1 yr, whereas in the acyanotic group, 17 of 25 were ≤12 months, five subjects were 1.1-4 yr, and three subjects were 4.1-7 yr. This explains differences in patient characteristic parameters between the cyanotic and acyanotic groups (Table 1) , and consideration of age-adjusted reference values for platelet aggregation in the following text. 23 
Laboratory data
Mean platelet count was within the normal range in cyanotic and acyanotic patients with no intergroup differences. Time course of platelet count before and after cardiac surgery is shown in Figure 1A . Time course of platelet aggregation in the ADP test, TRAP test, and ASPI test before and after cardiac surgery is shown in Figure 1B -D. Before surgery, aggregation responses to all agonists were in the age-adjusted reference range in cyanotic children. Platelet aggregation was below the age-adjusted lower range at baseline in acyanotic children and significantly lower compared with the cyanotic group. In the small subgroup of acyanotic children older than 1 yr (n¼8), aggregation values were slightly lower compared with the younger acyanotic population.
Platelet aggregation in response to all tested agonists decreased significantly during surgery in both groups below the reference range. Platelet function recovered in both groups but did not reach baseline levels until the fifth postoperative day.
Intra-and postoperative bleeding and transfusions
Bleeding and transfusion frequencies are summarized in Table 2 . Children with cyanotic malformations had higher intraoperative blood loss per body weight compared with acyanotic subjects.
The number of subjects receiving RBC concentrates and FFP was comparable between the groups. Platelet concentrate transfusion occurred more often in cyanotic subjects compared with acyanotic subjects ≤12 months of age. Platelet aggregation in the ADP test before surgery correlated inversely with intraoperative RBC transfusion requirements (r¼20.41, P¼0.0054). Neither platelet count nor platelet aggregation parameters correlated with blood loss and platelet transfusion requirements. Platelet counts were ,100 g litre 21 before transfusion in 88% of subjects receiving platelet concentrates, while platelet aggregation was below the age-adjusted reference range in 100%. Fifty-four per cent of subjects received no platelet transfusion but had abnormal platelet counts and abnormal platelet aggregation.
No subject underwent re-exploration due to diffuse bleeding and all children had an uncomplicated postoperative period.
Discussion
The present investigation partially confirms previous findings that children with CHD have compromised platelet function. 2 7 Despite normal platelet counts, platelet aggregation in response to all tested agonists was below the age-adjusted reference range in acyanotic children before surgery. In cyanotic children, however, the aggregation response was within the reference range of healthy neonates and infants. This finding indicates that cyanosis per se does not inhibit platelet aggregation. Shear stress-induced overproduction of procoagulant platelet microparticles in cyanotic CHD has been reported, 8 and might explain the increased platelet aggregation response in the cyanotic group (Fig. 1B -D) . Platelet activation and endothelial dysfunction causing an enhanced procoagulant potential have further been suggested to play an important role in the increased rate of thromboembolic events in patients with cyanotic CHD. Point-of-care assessment of platelet aggregation The mechanism of platelet inhibition in acyanotic patients remains unclear. Medication such as antibiotics, prostaglandins, analgesic drugs, or direct anti-platelet drugs can have side-effects on platelet aggregation but acyanotic paediatric patients are not routinely exposed to such substances. Horigome and colleagues 8 reported a negative correlation between haematocrit, platelet count, and aggregability. However, in our patients, both haemoglobin levels and platelet count were comparable in children with cyanotic and acyanotic malformations. Cardiac surgery with CPB leads to impaired haemostasis. Suggested mechanisms include platelet exhaustion, hyperfibrinolysis, decreased clotting factor activities due to haemodilution, activation, and increased consumption. 25 MEA is dependent upon platelet counts; for counts ,80-100 g litre
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, MEA generates only a qualitative estimation of platelet aggregation during CPB. In our study, platelet aggregability decreased during surgery to a similar level in both groups. Preoperative platelet inhibition in acyanotic children did not aggravate CPB-related platelet impairment. This finding suggests that preoperative platelet aggregability does not determine the course of platelet dysfunction during cardiac surgery.
Interestingly, platelet response to the strong agonist TRAP remained within the reference range in cyanotic patients even after CPB while the response to the weak platelet agonists ADP and ASPI was below normal. The reason for the low dual response remains to be determined at the molecular level, for example, by flow cytometry.
Slow recovery of platelet aggregability did not reach baseline levels until the fifth postoperative day, despite adequate clinical haemostasis. In adults, a rapid increase in platelet reactivity has been observed. 26 Therapeutic interventions might enhance platelet recovery. Platelet transfusion corrects thrombocytopenia 27 and thrombopathia, 21 28 and desmopressin improves platelet adhesion. 29 Further interventional studies are warranted to test the effect of these haemostatic options on periperative bleeding tendency and transfusion needs in the case of positive pre-test probability (decreased aggregation in MEA).
A limitation of this study with respect to the clinical outcome parameters is the small sample size of 50 subjects. Accordingly, the study was not powered to analyse differences in bleeding tendency and transfusion requirements. Furthermore, the clinical management was not controlled in the observational study design and platelet concentrate transfusions were at the clinician's discretion. Nevertheless, it is noteworthy that despite better overall platelet responsiveness platelet concentrate transfusions occurred more frequently and cumulative weight-adjusted blood loss was higher in the cyanotic population (Table 2) . Haemostasis involves a balance of plasmatic and cellular elements and it is likely that the overall balance is shifted towards hypocoagulability in cyanosis, despite adequate platelet aggregability. 2 30 Furthermore, young age and complexity of the surgical procedure could be major risk factors for perioperative bleeding in the cyanotic population. Neither platelet count nor platelet aggregation parameters correlated to blood loss and platelet transfusion requirements. Although statistically significant, the correlation between ADP test before surgery and intraoperative RBC transfusion requirements was weak (r¼20.41). While MEA was found to be predictive for platelet concentrate transfusion in adult patients undergoing cardiac surgery, 21 28 monitoring of platelet aggregation alone might not be suitable for identifying a perioperative disposition for increased blood loss and transfusion requirements in the paediatric population.
